We welcome Biotalys and Novonesis announced a manufacturing and commercialisation partnership for Evoca NG. Leveraging Novonesis' world leading fermentation capabilities can not only add value to Biotalys' very promising Agrobody technology but (as Novonesis is one of the leaders in the field of biosolutions) this can as well be seen as an important step forward for Biotalys as they lay the foundation for future commercial launches from its Agrobody 2.0 technology platform. We reiterate our Buy ...
No major surprises out of Biotalys' FY23 update as the company continues its work with the EPA for regulatory approval of Evoca. Meanwhile, new management fine-tuned the technology platform and restructured the pipeline with BioFun-6 now coming forward as the next candidate for field trials. Cash landed higher than expected at € 21.6m, implying runway until April 2025. We maintain our conviction in Biotalys' technology while we await a regulatory decision, and reiterate our € 6.0 TP and Buy rati...
Company updates written at the occasion of our annual Local Champions Mid Cap Event set to take place on Thursday, 14 December 2023 at our historic building at Grand Place in Brussels. This event offers the possibility to have one-on-one meetings and/or attend small group sessions with the top management of the below listed companies. AGFA | BARCO | BEKAERT | BIOTALYS | DECEUNINCK | EKOPAK | EVS | FAGRON | FLUXYS | IBA | ONTEX | TINC | XFAB
Biotalys' 1H23 results will be overshadowed by the news that the US Environmental Protection Agency (EPA) has recently changed its review process and no longer sets dates for expected decisions to applicants (until now Biotalys indicated they expect the review by EPA for 3Q23). Biotalys continues to work with the EPA as it reviews the submitted regulatory dossier. Pending regulatory approval, Biotalys is preparing for the start of the market calibration with Evoca in 2024 and for the launch of t...
Biotalys is a green AgTech, Agricultural Technology, company that develops biological crop and food protection products based on a proprietary antibody-based technology shaping the future of sustainable and safe food supply. Recently we saw huge validation of its platform as Syngenta will use it to expand its insecticide biocontrol pipeline. Using its proprietary technology, the AGROBODY Foundry™ platform, Biotalys aim is to develop products that help reduce agriculture's environmental footpri...
Syngenta Crop Protection and Biotalys announced a collaboration to research, develop and commercialize new biocontrol solutions to manage key pests in a broad variety of crops. We see this as a huge validation of Biotalys' platform. The new solution will be based on Biotalys' AGROBODY technology and will offer a new mode of action to broaden farmers' access to novel technologies that counter the threat of pest resistance and advance sustainable agriculture. No financial specifics were disclosed ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.